z-logo
Premium
Reduced type I collagen utilization: A pathogenic mechanism in COL5A1 haplo‐insufficient Ehlers–Danlos syndrome
Author(s) -
Wenstrup Richard J.,
Florer Jane B.,
Cole William G.,
Willing Marcia C.,
Birk David E.
Publication year - 2004
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.20024
Subject(s) - hydroxyproline , type i collagen , collagen, type i, alpha 1 , collagen fibril , ehlers–danlos syndrome , osteogenesis imperfecta , fibroblast , chemistry , collagen receptor , matrix (chemical analysis) , connective tissue , fibril , matrix metalloproteinase , proline , procollagen peptidase , extracellular matrix , endocrinology , biophysics , cell , biochemistry , anatomy , pathology , biology , in vitro , medicine , amino acid , chromatography , integrin alpha m
To examine mechanisms by which reduced type V collagen causes weakened connective tissues in the Ehlers–Danlos syndrome (EDS), we examined matrix deposition and collagen fibril morphology in long‐term dermal fibroblast cultures. EDS cells with COL5A1 haplo‐insufficiency deposited less than one‐half of hydroxyproline as collagen compared to control fibroblasts, though total collagen synthesis rates are near‐normal because type V collagen represents a small fraction of collagen synthesized. Cells from patients with osteogenesis imperfecta (OI) and haplo‐insufficiency for proα1(I) chains of type I collagen also incorporated about one‐half the collagen as controls, but this amount was proportional to their reduced rates of total collagen synthesis. Collagen fibril diameter was inversely proportional to type V/type I collagen ratios (EDS > control > OI). However, a reduction of type V collagen, in the EDS derived cells, was associated with the assembly of significantly fewer fibrils compared to control and OI cells. These data indicate that in cell culture, the quantity of collagen fibrils deposited in matrix is highly sensitive to reduction in type V collagen, far out of proportion to type V collagen's contribution to collagen mass. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here